We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-13.83%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.51B
AUM Growth
-$1.01B
Cap. Flow
+$139M
Cap. Flow %
2.14%
Top 10 Hldgs %
20.49%
Holding
891
New
87
Increased
331
Reduced
275
Closed
84

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$60.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$30.7M
3
BIIB icon
Biogen
BIIB
+$19.7M
4
MA icon
Mastercard
MA
+$18.7M
5
BMY icon
Bristol-Myers Squibb
BMY
+$18M

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$32.8M
2
EC icon
Ecopetrol
EC
+$29.1M
3
AET
Aetna Inc
AET
+$20.2M
4
XOM icon
ExxonMobil
XOM
+$19.6M
5
AMGN icon
Amgen
AMGN
+$19.2M

Sector Composition

Rank Sector Weight
1 Healthcare 35.31%
2 Technology 15.37%
3 Financials 11.61%
4 Consumer Discretionary 8.19%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRU icon
76
Prudential Financial
PRU
$41.7B
$18.2M 0.28%
223,665
-13,520
-6% -$1.25M
NVDA icon
77
NVIDIA
NVDA
$5.01T
$18.1M 0.28%
5,414,320
+842,120
+18% +$4.03M
ANET icon
78
Arista Networks
ANET
$219B
$17.8M 0.27%
1,353,136
-135,600
-9% -$1.95M
INTU icon
79
Intuit
INTU
$81.1B
$17.3M 0.27%
88,006
+29,481
+50% +$6.13M
AERI
80
DELISTED
Aerie Pharmaceuticals
AERI
$17.3M 0.27%
478,800
+152,000
+47% +$7.13M
MMM icon
81
3M
MMM
$89B
$17.2M 0.26%
107,976
+12,662
+13% +$2.1M
LLY icon
82
Eli Lilly
LLY
$1.07T
$17.1M 0.26%
147,702
-14,379
-9% -$1.61M
TJX icon
83
TJX Companies
TJX
$170B
$16.9M 0.26%
378,251
+64,751
+21% +$3.27M
MET icon
84
MetLife
MET
$61B
$16.9M 0.26%
411,929
-9,502
-2% -$408K
APD icon
85
Air Products & Chemicals
APD
$66.3B
$16.9M 0.26%
105,338
+10,049
+11% +$1.59M
KPTI icon
86
Karyopharm Therapeutics
KPTI
$168M
$16.8M 0.26%
119,503
+47,136
+65% +$7.95M
BLUE
87
DELISTED
bluebird bio
BLUE
$16.8M 0.26%
13,055
+5,057
+63% +$7.76M
GE icon
88
GE Aerospace
GE
$367B
$16.5M 0.25%
455,380
+7,648
+2% +$345K
NBIX icon
89
Neurocrine Biosciences
NBIX
$17.7B
$16.3M 0.25%
228,069
+78,000
+52% +$7.47M
KYNB
90
Kyntra Bio
KYNB
$28.5M
$16.2M 0.25%
14,036
-2,400
-15% -$2.7M
RARX
91
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$16M 0.25%
879,000
+444,000
+102% +$6.97M
DD icon
92
DuPont de Nemours
DD
$18.6B
$16M 0.25%
117,838
+21,122
+22% +$3.03M
PCAR icon
93
PACCAR
PCAR
$69.6B
$15.9M 0.24%
418,257
-924
-0.2% -$36.9K
PANW icon
94
Palo Alto Networks
PANW
$264B
$15.8M 0.24%
502,458
-198
-0% -$6.17K
COP icon
95
ConocoPhillips
COP
$147B
$15.7M 0.24%
252,488
-165,508
-40% -$11.3M
BAC icon
96
Bank of America
BAC
$435B
$15.5M 0.24%
628,104
+194,165
+45% +$5.27M
CL icon
97
Colgate-Palmolive
CL
$72.6B
$15.4M 0.24%
259,494
+14,727
+6% +$921K
KO icon
98
Coca-Cola
KO
$354B
$15.4M 0.24%
324,861
-67,782
-17% -$3.24M
BIDU icon
99
Baidu
BIDU
$35.8B
$15.4M 0.24%
96,874
-3,244
-3% -$605K
SAGE
100
DELISTED
Sage Therapeutics
SAGE
$15.4M 0.24%
160,300
+22,500
+16% +$2.57M
2 3
4
5 6

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2018 Portfolio in Review

As of Q4 2018, Candriam SCA held 891 positions worth $6.51B, down 13% from $7.52B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q4 2018 filing shows 87 new, 331 increased, 275 reduced and 84 closed positions. Its largest new stake was Azul: 501,000 shares worth $13.9M. The largest sale was TESARO, Inc., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2018 buy was Azul: 501,000 shares worth $13.9M.
  • Candriam SCA added most to Celgene Corp in Q4 2018, an estimated $60.9M increase.
  • Candriam SCA's biggest Q4 2018 reduction was TESARO, Inc., cutting an estimated $32.8M.
  • Candriam SCA fully exited Aetna Inc in Q4 2018, selling an estimated $20.2M.
  • Candriam SCA's ten largest holdings make up 20% of its $6.51B portfolio in Q4 2018.
  • Candriam SCA opened 87 new positions and closed 84 in Q4 2018.
  • Candriam SCA's portfolio value fell 13% quarter-over-quarter to $6.51B.

Based on Candriam SCA's 13F filing for Q4 2018, filed 14 Feb 2019.